Edwards Lifesciences Corporation

符号: EW

NYSE

85.25

USD

今天的市场价格

36.2756
市盈率
2.3277
PEG比率
51.37B
MRK市值
0.00%
DIV收益率

Edwards Lifesciences Corporation (EW) 财务报表

Q: 什么是 Edwards Lifesciences Corporation (EW) 总资产是多少？

Edwards Lifesciences Corporation (EW) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Edwards Lifesciences Corporation (EW). 的默认数据。公司收入显示 2317.808 M 的平均值，即 0.086 % 增长率。整个期间的平均毛利润为 1683.372 M，即 0.103 %. 平均毛利率为 0.679 %. 公司去年的净收入增长率为 -0.079 %，等于 1.845 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Edwards Lifesciences Corporation 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.000. 在流动资产领域，EW 的报告货币为4035.7. 这些资产中的很大一部分，即 1644.5 是现金和短期投资。与去年的数据相比，该部分的变化率为0.353%. 公司的长期投资虽然不是其重点，但以报告货币计算的583.9（如果有的话）为583.9。这表明与上一报告期相比，-52.873% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 670. 这一数字表明，0.000% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 6650. 这方面的年同比变化率为 0.145%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为836.9，存货估值为 1168.2，商誉估值为 1253.5（如有. 无形资产总额（如果有）按 428.4 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
balance-sheet.row.cash-and-short-term-investments	6715.3	1644.5	1215.3	1466.8	1402.6	1516.9	956.5	1337.5	1271.1	1224.7	1438.8	936.9	521.4	450.5	396.1	334.1	226.8	191.2	182.8	178.6	48.9	61.1	34.2	48	28	13
balance-sheet.row.short-term-investments	1894	500.5	446.3	604	219.4	337.8	242.4	519.2	341	506.3	785	516.5	210.5	279.3	0	0	8.1	49.4	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	3332.8	836.9	699.1	664.9	602.8	599.1	537.3	462.2	414.6	344.1	325	328	347.5	320.7	302.5	272.1	204.7	145.3	127.1	118.5	119.4	118.5	108.4	101	129	155
balance-sheet.row.inventory	4388.1	1168.2	875.5	726.7	802.3	640.9	607	554.9	396.6	339.9	296.8	308.9	281	261.3	203.6	165.9	151.8	152.6	142.1	131.5	127.7	120.5	111.8	87	73	169
balance-sheet.row.other-current-assets	1081.2	239.3	195.9	237.1	208.2	168	131.8	116.9	111.8	94.1	121.7	71.8	57	57.1	43.1	35.1	35.5	37	79.6	10.5	8.2	6.4	23.4	20	15	19
balance-sheet.row.total-current-assets	15920.7	4035.7	3095.8	3180.7	3091	2984	2286.9	2532.1	2240	2047.9	2294.6	1725.8	1291.9	1168.5	1032.6	889.2	691.9	581.7	531.6	514.2	367.5	360.2	326.4	293	282	356
balance-sheet.row.property-plant-equipment-net	7229	1843.4	1725.1	1638.7	1489.4	1140.4	867.5	679.7	580	482.5	442.9	421.6	373.3	304.3	269.8	252	230.1	228.2	213	201.9	201.7	209.9	209.4	178	183	226
balance-sheet.row.goodwill	5103.2	1253.5	1164.3	1167.9	1173.2	1167.7	1112.2	1126.5	626.1	628.3	376	385.4	384.7	349.8	315.2	315.2	315.7	350.3	337.7	337.7	337.7	338.2	333.8	402	0	0
balance-sheet.row.intangible-assets	1736.4	428.4	285.2	323.6	331.4	336.5	343.2	468	204.8	205.4	23.4	57.2	67	66.9	67.1	86.7	96.9	122.5	116.1	475.4	490.3	419.2	395.7	0	511	0
balance-sheet.row.goodwill-and-intangible-assets	6839.6	1681.9	1449.5	1491.5	1504.6	1504.2	1455.4	1594.5	830.9	833.7	399.4	442.6	451.7	416.7	382.3	401.9	412.6	472.8	453.8	475.4	490.3	419.2	395.7	402	511	839
balance-sheet.row.long-term-investments	2600.3	583.9	1239	1834.2	801.6	585.5	506.3	567	532.1	379.9	240.9	21.9	21.1	21.8	25	22.3	14.7	34	20	11	20.6	35.4	23.5	93	0	1
balance-sheet.row.tax-assets	2793.9	754.6	484	246.7	230.9	172.2	174	214.3	203.8	180.5	91.5	70.1	47.3	20	44.5	37.1	37.7	13.8	14.5	11.5	22.3	59.3	38.8	18	0	0
balance-sheet.row.other-non-current-assets	2090.8	463.7	299.1	110.8	119.6	101.8	33.6	108.9	123.2	134.8	55	42.7	36.2	49.2	13	13	13.2	14.6	13.9	15.1	10.3	17.4	14.4	-11	112	15
balance-sheet.row.total-non-current-assets	21553.6	5327.5	5196.7	5321.9	4146.1	3504.1	3036.8	3164.4	2270	2011.4	1229.7	998.9	929.6	812	734.6	726.3	708.3	763.4	715.2	714.9	745.2	741.2	681.8	680	806	1081
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	37474.3	9363.2	8292.5	8502.6	7237.1	6488.1	5323.7	5696.5	4510	4059.3	3524.3	2724.7	2221.5	1980.5	1767.2	1615.5	1400.2	1345.1	1246.8	1229.1	1112.7	1101.4	1008.2	973	1088	1437
balance-sheet.row.account-payables	1671	201.4	201.9	204.5	196.5	180.4	134	116.6	97.1	63.9	58.2	48.4	74.7	85	47.6	51.1	65.6	63.9	57.2	194.2	195.4	167.2	197.9	183	158	0
balance-sheet.row.short-term-debt	98.3	24.9	25.5	25.5	27.2	25.5	0	598	0	0	0	0	0	0	41.8	0	0	150	0	0	0	0	0	1	61	0
balance-sheet.row.tax-payables	440.9	122.3	96.2	99.5	68.3	104.3	70.8	139.7	41.2	49	41.8	38.7	40.5	37.5	22.3	35.9	6.2	0	37	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	2594.2	670	665.8	664.8	667.7	653.3	593.8	438.4	822.3	599.9	598.1	593.1	189.3	150.4	0	90.3	175.5	61.7	235.9	316.1	267.1	255.8	245.5	310	367	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3448.7	15.2	311	3.9	39.3	6.4	742.6	51.7	435.4	412.3	376.2	297.2	272.7	250.2	226.1	239.4	192.9	161.5	169	0	0	0	0	183	0	156
balance-sheet.row.total-non-current-liabilities	5692.6	1448.4	1463.4	1634.4	1768.9	1437.4	1306.7	1302.4	1358.5	1080	898.5	819.9	394.8	307.4	121.2	167.1	262.9	134.7	271.2	344.9	289.2	299.1	270.9	330	429	57
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	357.2	97.9	95	94.6	99.9	84.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	10394.9	2643.8	2485.8	2666.7	2662.8	2339.8	2183.3	2701.8	1891	1556.2	1332.9	1165.5	742.2	642.6	459	457.6	521.4	510.1	497.4	539.1	484.6	466.3	468.8	514	648	213
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2601.3	650.5	646.3	642	636.4	218.1	215.2	212	242.6	239.1	128.9	126	124.2	120	117	76.1	73.7	68.6	67	65.6	64.2	62.6	60.2	59	59	0
balance-sheet.row.retained-earnings	35196.8	8992.4	7590	6068.1	4565	3741.6	2694.7	2000.6	3906.3	3336.8	2841.9	2045.6	1653.9	1360.7	1124	906	676.9	548.6	433.9	303.4	224.1	222.4	143.4	88	103	418
balance-sheet.row.accumulated-other-comprehensive-income-loss	-981.7	-242.8	-254.9	-157.7	-161.1	-156	-138.5	-132.7	-198.4	-182.6	-100.9	-27.6	-37.9	-37.5	-42.1	-7.9	-35.4	7.5	-15.8	-22.2	-20.8	-32.2	-44.7	26	1	-27
balance-sheet.row.other-total-stockholders-equity	-10015.3	-2750.1	-2174.7	-716.5	-466	344.6	369	914.8	-1331.5	-890.2	-678.5	-584.8	-260.9	-105.3	109.3	183.7	163.6	210.3	264.3	343.2	360.6	382.3	380.5	286	277	833
balance-sheet.row.total-stockholders-equity	26801.1	6650	5806.7	5835.9	4574.3	4148.3	3140.4	2994.7	2619	2503.1	2191.4	1559.2	1479.3	1337.9	1308.2	1157.9	878.8	835	749.4	690	628.1	635.1	539.4	459	440	1224
balance-sheet.row.total-liabilities-and-stockholders-equity	37474.3	9363.2	8292.5	8502.6	7237.1	6488.1	5323.7	5696.5	4510	4059.3	3524.3	2724.7	2221.5	1980.5	1767.2	1615.5	1400.2	1345.1	1246.8	1229.1	1112.7	1101.4	1008.2	973	1088	1437
balance-sheet.row.minority-interest	278.3	69.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	27079.4	6719.4	5806.7	5835.9	4574.3	4148.3	3140.4	2994.7	2619	2503.1	2191.4	1559.2	1479.3	1337.9	1308.2	1157.9	878.8	835	749.4	690	628.1	635.1	539.4	459	440	1224
balance-sheet.row.total-liabilities-and-total-equity	37474.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	4494.3	1084.4	1685.3	2438.2	1021	923.3	748.7	1086.2	873.1	886.2	1025.9	538.4	231.6	301.1	25	22.3	22.8	83.4	20	11	20.6	35.4	23.5	93	0	1
balance-sheet.row.total-debt	2769.7	694.9	691.3	690.3	694.9	678.8	593.8	1036.4	822.3	599.9	598.1	593.1	189.3	150.4	41.8	90.3	175.5	211.7	235.9	316.1	267.1	255.8	245.5	311	428	0
balance-sheet.row.net-debt	-2051.6	-449.1	-77.7	-172.5	-488.3	-500.3	-120.3	218.1	-107.8	-118.5	-55.7	172.7	-121.6	-20.8	-354.3	-243.8	-43.2	69.9	53.1	137.5	218.2	194.7	211.3	263	400	0

现金流量表

在 Edwards Lifesciences Corporation 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.995 的转变。该公司最近通过发行 169.9 扩大了股本，与上一年相比出现了0.650 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到173800000.000. 与上一年相比， -0.311 发生了变化. 在同一时期，公司记录了 144.9, -75 和 -0.3，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-169.9 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 168.9，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
cash-flows.row.net-income	1409.9	1399.4	1521.9	1503.1	823.4	1046.9	722.2	583.6	569.5	494.9	811.1	391.7	293.2	236.7	218	229.1	128.9	113	130.5	79.3	1.7	79	55.7	-11	-272	82
cash-flows.row.depreciation-and-amortization	148.2	144.9	139.6	134.8	107.2	89.3	77.4	81.9	71.2	65.8	68.6	68.7	57.3	58	56.5	58.7	55.6	54.8	56.8	56.2	55.7	45.6	40.4	57	74	84
cash-flows.row.deferred-income-tax	-256.1	-272.1	-254.5	-41.4	-49.4	12.1	-27.3	17.8	-37.4	-95	-71.1	0.1	8.1	-0.6	-11.2	-4	-23.5	-5.6	7.1	-13.8	0.8	5.3	-13.8	-30	0	0
cash-flows.row.stock-based-compensation	145.1	139.4	126.8	109.3	92.6	81.3	71	61.6	56.9	49.9	48.3	47.4	42.1	35	29.3	28.3	28.7	27.7	26.6	0	0	0	0	82	0	0
cash-flows.row.change-in-working-capital	-928.7	-526.3	-421.4	145.3	42.2	-204.3	-42.6	234.2	66.1	64.4	190.3	21.5	11.5	-29.7	-1.1	-68.3	-69.5	4.1	-14.9	-3.6	2.8	-19.9	-36.3	-5	-12	-1
cash-flows.row.account-receivables	-348.9	-141.2	-84.1	-112.4	283.9	-94.8	-13	-3.9	-56.7	-38.3	-26.8	8.5	-26.5	-53.7	-34.2	-51.6	-68.5	-6.6	2.5	-12.6	7.1	-11	-32	0	0	0
cash-flows.row.inventory	-325.7	-289	-213.4	19	-120.6	-105.4	-65.7	-124	-65.6	-67.7	-30.5	-44.4	-21.7	-57	-36.8	-13.1	-17.8	-9	-12.8	-12.9	-7.1	4.2	13.3	-7	15	-14
cash-flows.row.account-payables	102.1	146	-21.4	195.2	-84.5	-63.5	192.5	85.2	74	29.4	112.9	50.3	41.9	61.7	63.6	-16.3	32.9	14	-3.9	25.1	13	-8.4	-17.6	0	0	0
cash-flows.row.other-working-capital	-378.1	-242.1	-102.5	43.5	-36.6	59.4	-156.4	276.9	114.4	141	134.7	7.1	17.8	19.3	6.3	12.7	-16.1	5.7	-0.7	-3.2	-10.2	-4.7	0	2	-27	13
cash-flows.row.other-non-cash-items	9.8	10.5	105.8	-119	38.3	154.1	126.1	21.6	-21.9	-30.3	-24.9	-56.7	-38.4	15.1	-40.1	-78.5	33	16.2	24.7	18.7	119.6	12.3	74.6	8	347	11
cash-flows.row.net-cash-provided-by-operating-activities	528.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-290.1	-266.3	-264.8	-329.8	-407.3	-278.4	-241.7	-175.5	-217.4	-106.5	-93.7	-110.1	-127.7	-90.6	-63	-64	-78	-62.5	-59.4	-48.5	-42.5	-37.9	-40.7	-38	-46	-42
cash-flows.row.acquisitions-net	149.2	-95.2	0	329.8	407.3	-100.2	-6.2	-184.6	-5.7	-333.7	-24.1	-2.7	-35.8	-42.6	-1.2	64	69.6	-37	0	0	-137.7	0	-19	0	0	-7
cash-flows.row.purchases-of-investments	-88.2	-105.5	-778.9	-1892.4	-861.7	-603.1	-471.9	-1347.4	-1074.9	-1318	-2131.2	-824.6	-593.2	-645.6	-7.3	-7.4	-1.3	-57.3	-1.8	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	618.5	715.8	1359.1	529.2	777	409.9	801.3	1103.4	1085.1	1439.7	1612.9	526.4	662.3	362.1	2.2	13.7	41	5.6	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-153	-75	-63.1	-359.3	-446.4	-24	-4.8	-43.1	1.2	2.4	3.1	-1.7	3.9	3.9	7.8	33.8	27.5	6.7	25.5	21.3	3.1	-25.4	-8.6	34	-29	0
cash-flows.row.net-cash-used-for-investing-activites	236.4	173.8	252.3	-1722.5	-531.1	-595.8	76.7	-647.2	-211.7	-316.1	-633	-412.7	-90.5	-412.8	-61.5	40.1	58.8	-144.5	-35.7	-27.2	-177.1	-63.3	-68.3	-4	-75	-49
cash-flows.row.debt-repayment	-0.3	-0.3	-0.2	-7	-17	-28.9	-1125.3	-818.4	-31.4	-29.5	-239	-895.4	-367.5	-421.7	-302.8	-213.9	-112.1	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	190.1	169.9	146.4	158.6	140.5	160.5	147	113.8	103.3	87.2	113.3	45.5	100.1	59.5	92.1	66.7	63.8	38.7	33.5	26.2	30.5	36.6	13.7	0	4	0
cash-flows.row.common-stock-repurchased	-630.5	-879.6	-1727.1	-512.8	-625.4	-263.3	-795.5	-763.3	-662.3	-280.1	-300.9	-496.9	-344.1	-303.4	-200	-95.5	-306.5	-130.9	-145.9	-53.5	-59.1	-49.4	-30.8	0	0	0
cash-flows.row.dividends-paid	0	-169.9	-146.4	-158.6	-140.5	-18.9	-688	0	-253.5	-31.4	-226.3	-1305	-407	-526.1	-254.4	-129.3	-206.3	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	30.9	168.9	142.8	163.5	155.5	35	1360.6	994.7	575.4	95.2	499.9	2686.7	862.9	1056.5	561.2	280.2	427	-15.9	-81.2	56.3	8.1	-2.2	-52.4	-78	-41	-127
cash-flows.row.net-cash-used-provided-by-financing-activities	-442.7	-711	-1584.5	-356.3	-486.9	-115.6	-1101.2	-473.2	-268.5	-158.6	-153	34.9	-155.6	-135.2	-103.9	-91.8	-134.1	-108.1	-193.6	29	-20.5	-15	-69.5	-78	-37	-127
cash-flows.row.effect-of-forex-changes-on-cash	30.7	16.8	19.2	13.9	-20.5	-3	-6.5	7.9	-12.5	-10.4	-2.9	14.6	12	8.6	-24	1.8	-1	1.4	2.7	-8.9	4.8	-17.1	3.7	1	3	0
cash-flows.row.net-change-in-cash	352.6	375.4	-94.8	-332.8	15.8	465	-104.2	-111.8	211.7	64.6	233.4	109.5	139.7	-224.9	62	115.4	76.9	-41	4.2	129.7	-12.2	26.9	-13.5	20	28	0
cash-flows.row.cash-at-end-of-period	4838.4	1148	772.6	867.4	1200.2	1179.1	714.1	818.3	930.1	718.4	653.8	420.4	310.9	171.2	396.1	334.1	218.7	141.8	182.8	178.6	48.9	61.1	34.2	48	28	0
cash-flows.row.cash-at-beginning-of-period	4485.8	772.6	867.4	1200.2	1184.4	714.1	818.3	930.1	718.4	653.8	420.4	310.9	171.2	396.1	334.1	218.7	141.8	182.8	178.6	48.9	61.1	34.2	47.7	28	0	0
cash-flows.row.operating-cash-flow	528.2	895.8	1218.2	1732.1	1054.3	1179.4	926.8	1000.7	704.4	549.7	1022.3	472.7	373.8	314.5	251.4	165.3	153.2	210.2	230.8	136.8	180.6	122.3	120.6	101	137	176
cash-flows.row.capital-expenditure	-290.1	-266.3	-264.8	-329.8	-407.3	-278.4	-241.7	-175.5	-217.4	-106.5	-93.7	-110.1	-127.7	-90.6	-63	-64	-78	-62.5	-59.4	-48.5	-42.5	-37.9	-40.7	-38	-46	-42
cash-flows.row.free-cash-flow	238.1	629.5	953.4	1402.3	647	901	685.1	825.2	487	443.2	928.6	362.6	246.1	223.9	188.4	101.3	75.2	147.7	171.4	88.3	138.1	84.4	79.9	63	91	134

利润表行

Edwards Lifesciences Corporation 的收入与上期相比变化了 0.116%。据报告, EW 的毛利润为 4625。该公司的营业费用为 2895.2，与上年相比变化了 15.218%. 折旧和摊销费用为 144.9，与上一会计期间相比变化了 0.780%. 营业费用报告为 2895.2，显示15.218% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.123%. 营业收入为 1534.1，与上年相比变化了-0.123%. 净利润的变化率为 -0.079%。去年的净收入为1402.4.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
income-statement-row.row.total-revenue	6143.4	6004.8	5382.4	5232.5	4386.3	4348	3722.8	3435.3	2963.7	2493.7	2322.9	2045.5	1899.6	1678.6	1447	1321.4	1237.7	1091.1	1037	997.9	931.5	860.5	704	692	804	905
income-statement-row.row.cost-of-revenue	1434.5	1379.8	1080.4	1248.9	1080.6	1114.4	939.4	875.3	797.4	617.2	625.6	522.4	494.6	489.8	408.3	399.1	419.6	378.2	373.6	374.6	370.2	359.4	299.1	324	423	466
income-statement-row.row.gross-profit	4708.9	4625	4302	3983.6	3305.7	3233.6	2783.4	2560	2166.3	1876.5	1697.3	1523.1	1405	1188.8	1038.7	922.3	818.1	712.9	663.4	623.3	561.3	501.1	404.9	368	381	439
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	1095.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.4	3.4	2.6	12.7	11.5	8.2	4	-8.2	-4.9	-4	-7.7	-1.3	-1.7	0	0	0	0	0	0	0	0	0	59.7	86	15	34
income-statement-row.row.operating-expenses	2974	2895.2	2512.8	2396.8	1989.1	1994.9	1710.7	1537.3	1348	1233.8	1204.5	1068.6	996.6	888.7	754.4	684.3	643.8	540.3	490.2	447.7	406.9	362.7	352.8	344	286	322
income-statement-row.row.cost-and-expenses	4408.5	4275	3593.2	3645.7	3069.7	3109.3	2650.1	2412.6	2145.4	1851	1830.1	1591	1491.2	1378.5	1162.7	1083.4	1063.4	918.5	863.8	822.3	777.1	722.1	651.9	668	709	788
income-statement-row.row.interest-income	30.5	67.2	35.5	17.4	23.4	11.5	32	20.3	10.8	7.9	6.4	4.6	0.4	3.4	0.9	1.6	6.1	-7.7	-7.8	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	27.8	17.6	19.2	18.4	15.8	20.7	-2.1	2.9	8.4	9.3	10.8	5.2	4.4	3.1	2.4	1.1	7.2	9.1	10.5	9.7	14.2	13.2	11.5	23	0	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-167	-181.3	18.9	353.5	-711.7	19.7	-313.4	15.1	-72	-11	662	66	-17.7	-16.8	-14.6	67.5	-32.8	-21.4	1.8	-49.2	-110.1	-32.4	-44.3	-77	-320	4
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.4	3.4	2.6	12.7	11.5	8.2	4	-8.2	-4.9	-4	-7.7	-1.3	-1.7	0	0	0	0	0	0	0	0	0	59.7	86	15	34
income-statement-row.row.total-operating-expenses	-167	-181.3	18.9	353.5	-711.7	19.7	-313.4	15.1	-72	-11	662	66	-17.7	-16.8	-14.6	67.5	-32.8	-21.4	1.8	-49.2	-110.1	-32.4	-44.3	-77	-320	4
income-statement-row.row.interest-expense	27.8	17.6	19.2	18.4	15.8	20.7	-2.1	2.9	8.4	9.3	10.8	5.2	4.4	3.1	2.4	1.1	7.2	9.1	10.5	9.7	14.2	13.2	11.5	23	0	0
income-statement-row.row.depreciation-and-amortization	78	144.9	81.4	134.8	107.2	183.8	77.4	81.9	71.2	65.8	68.6	68.7	57.3	58	56.5	58.7	55.6	54.8	56.8	56.2	55.7	45.6	40.4	57	74	84
income-statement-row.row.ebitda-caps	1886.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1583.4	1534.1	1748.5	1348.5	1628.4	1146.8	748.2	1022.7	783.8	642.7	482.6	454.5	408.4	300.1	284.3	238	198.3	172.6	173.2	175.6	154.4	138.4	52.1	24	95	117
income-statement-row.row.income-before-tax	1608.9	1598.1	1767.4	1702	916.7	1166.5	761.4	1034.9	737.9	622.4	1144	515.3	391.1	283.6	268.2	304.4	164.4	149.8	172.3	116.7	30.1	92.8	56	-9	-259	113
income-statement-row.row.income-tax-expense	199	198.7	245.5	198.9	93.3	119.6	39.2	412.8	168.4	127.5	332.9	123.6	97.9	46.9	50.2	75.3	35.5	36.8	41.8	37.4	28.4	13.8	0.3	1	13	31
income-statement-row.row.net-income	1413.8	1402.4	1521.9	1503.1	823.4	1046.9	722.2	622.1	569.5	494.9	811.1	391.7	293.2	236.7	218	229.1	128.9	113	130.5	79.3	1.7	79	55.7	-12	-272	82